Tuesday, May 23, 2017
 
 
Company News: Page (1) of 1 - 05/19/17 Email this story to a friend. email article Print this page (Article printing at MyDmn.com).print page facebook
Latest Osteoporosis Market and Forecast Analysis Research - Research and Markets
 
(May 19, 2017)

DUBLIN, May 19, 2017 /PRNewswire/ --

Research and Markets has announced the addition of the "Osteoporosis Market and Forecast Analysis" report to their offering.

Research and Markets Logo

Osteoporosis is the most common metabolic bone disorder, and is characterized by low bone mass accompanied by microarchitectural deterioration of bone tissue. The consequent increase in bone fragility results in osteoporosis patients being prone to sustaining fractures. Although the majority of osteoporosis patients are postmenopausal women, it is not a female-only disease.


It is estimated that one in three women and one in five men aged over 50 years will sustain an osteoporosis-related fracture, and the associated complications represent a huge socioeconomic burden. Treatment of osteoporosis can be a challenge as bone loss is essentially symptomless until a fracture occurs, which can lead to difficulties with diagnosis and patient compliance.

Key Topics Covered:

1. EPIDEMIOLOGY: OSTEOPOROSIS

  • Forecast: Osteopenia
  • Forecast: Osteoporosis
  • Epidemiologist Insight
  • Strengths and Limitations

2. MARKETED DRUGS: OSTEOPOROSIS

  • Product Overview
  • Bisphosphonates
  • Estrogens and SERMs
  • Calcitonin
  • Other Drug Classes
  • Product profile: Forteo
  • Product profile: Prolia

3. PIPELINE: OSTEOPOROSIS

  • Clinical Pipeline Overview
  • Comparator Therapy
  • Recently Discontinued Drugs
  • Product profile (late stage): Evenity
  • Product profile (late stage): abaloparatide

For more information about this report visit http://www.researchandmarkets.com/research/3sh4lf/osteoporosis

Media Contact:

Laura Wood, Senior Manager
press@researchandmarkets.com 

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

 



To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/latest-osteoporosis-market-and-forecast-analysis-research---research-and-markets-300460608.html

SOURCE Research and Markets

Copyright 2014 PR Newswire. All Rights Reserved


Page: 1


Related Keywords:Medicine, Disease, Surgery, Medication, Men, Women,
Related Sites: HTN - Health Technology Net
Related Newsletter: Tutorial Finder ,   Review Seeker ,   DMN Newswire Newsletter
 
 
 
 
 
 
 
 
 
 





Our Privacy Policy --- About The Health Technology - Contact Us - Advertise With Us - Privacy Guidelines